Cutler Group LP Kempharm, Inc Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$4.02 - $5.21 $38,189 - $49,495	-9,500 Reduced 55.88%	7,500 $2,000
Q1 2022 Apr 14, 2022	BUY	$5.0 - $9.26 $40,000 - $74,080	8,000 Added 88.89%	17,000 $3,000
Q4 2021 Jan 18, 2022	SELL	$7.6 - $10.26 $162,640 - $219,564	-21,400 Reduced 70.39%	9,000 $13,000
Q3 2021 Oct 26, 2021	SELL	$8.72 - $13.31 $49,704 - $75,867	-5,700 Reduced 15.79%	30,400 $67,000
Q2 2021 Jul 19, 2021	BUY	$8.52 - $15.47 $170,400 - $309,400	20,000 Added 124.22%	36,100 $149,000
Q1 2021 Apr 26, 2021	BUY	$5.6 - $13.47 $90,160 - $216,867	16,100 New	16,100 $15,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.